; News - New York Chapter of the American College of Physicians


November 12, 2020

Lung Cancer Diagnosis Decline During COVID-19
Click here for patient toolkit and infographic

The US has seen a significant disruption in cancer care and diagnosis due to COVID-19, including an alarming decline in lung cancer diagnoses. Despite relatively stable diagnosis rates for 13 months before the pandemic, recent data show an average ~49% decline in the number of lung cancer diagnoses across states most severely impacted by COVID-19.  Moreover, diagnoses in NY as of May 2020 have declined by 55% compared to the pre-COVID baseline timeframe of January 2019 through February 2020.[1]
As physicians, you know that this decline does not mean that fewer people are developing lung cancer, but rather that more people are facing significant delays in treatment, or worse, going completely undiagnosed – which may lead to poorer outcomes as treatment options are more limited for advanced stages of disease. As a result of the decline in diagnoses, an increase of excess cancer deaths is predicted over the next decade due to missed screenings, delays in diagnosis, and reductions in oncology care caused by the pandemic.
Despite the risks and challenges associated with COVID-19, it remains important for people to stay connected with their health care providers, especially those who are at increased risk for developing lung cancer.
November is Lung Cancer Awareness Month. If you would like to promote lung cancer screening awareness to your patients, please feel free to use the the toolkit and infographic available in NYACP's Practice Management Tools. If we all share the importance of lung cancer screenings with our patients, we can improve diagnoses throughout NY!

[1]This is based on information licensed from IQVIA Oncology Real World Insights for the period of January 2019 to May 2020 reflecting estimates of real-world activity.  All rights reserved. Study details and information maintained by AstraZenaca.

Did you miss the NYACP Annual Meeting?
You can still view all recordings and earn up to 12 CME Credits and 12 MOC points! ACP Member fee is $50 and you have until Spring 2021 to view your recordings and claim your credits.

Find all information on the NYACP Website!

What Members Are Saying
Responses to Recent Questions from NYACP

On COVID-19 Vaccine distribution in NY and physician participation in NYSIIS:  

Background: New York State is working on a plan to distribute COVID-19 vaccines when they become available. It is anticipated that eligibility to distribute the vaccine will require a physician to be a registered user of the NYS Immunization Information System (NYSIIS).


Why is it important?  To inform conversations related to COVID-19 vaccine distribution.

On a Call for Speakers for NYACP’s 2021 Annual Meeting:   

When we asked Members for suggested speakers and topics for the 2021 Annual Meeting, Members responded:

Thank you to everyone who responded to these calls for feedback. Your input is invaluable to us!

Let’s Get Social! 

Connect with NYACP Members

In between meetings, district events, and webinars, stay in touch with NYACP and fellow members by growing your social media network.  We have 4 options for you to connect, share, learn about member accomplishments and register for upcoming events.  Look for even more educational opportunities on social media in 2021!

Don’t forget to tag, share and use #NYACP.  We love to hear what members are doing!






ACP Webinar
Advancing to ACP Fellowship

Wednesday, November 18, 2020
3:00–4:00 p.m. ET

Join Matthew B. Carroll, MD, FACP, FACR, Chair of ACP's Credentials Committee, as he reviews the meaning and requirements for ACP Fellowship—a mark of honor and distinction within the internal medicine community. Each year, ACP Fellows are celebrated and inducted at ACP’s annual Internal Medicine Meeting during the Convocation Ceremony. For more information about ACP Fellowship and to access application materials in advance of the webinar, visit www.acponline.org/facp.


Advances in Cardiovascular Risk Reduction

December 3, 2020 • 7:45 AM-4:30 PM

Featuring a COVID-19 Presentation and Case Conference:  Platelet expert and lead investigator, Dr. Jeffrey Berger, will share results from the Anticoagulation Strategies in COVID-19 clinical trial.  Dr. Berger will present Challenging Cases in Antithrombotic Therapy, highlighting strategies to prevent clotting events in COVID-19 positive inpatients.

Jointly provided by NYU Grossman School of Medicine and the New York Chapter American College of Physicians and Offering 7.5 AMA PRA Category 1 Credits™

Registration and Conference Details


Contact Us

PO Box 38237 | Albany, NY 12203

Connect With Us

2020 New York Chapter of the American College of Physicians All Rights Reserved.